The Task-force in Europe for Drug Development for the Young (TEDDY) is a Network of Excellence (NoE) funded in 2005 as a consortium responding to a call published by the European Commission and aimed at “structuring efforts devoted to the development of medicines tailored for children”.
Between 2005-2010, the FP6 TEDDY project (LSHB-CT-2005-005216) played a critical role in the start-up of paediatric activities in Europe, in parallel with the introduction of the new European Paediatric Regulation.
Since 2010 TEDDY has revised its organisation and gathered research centres and groups willing to be engaged in developing clinical research. Today, TEDDY is an independent multidisciplinary, multinational Network composed of partners from 15 countries aimed at facilitating the performance of good quality paediatric studies and research.
TEDDY is a category 1 network member of Enpr-EMA, the European Network of Paediatric Research at the European Medicines Agency.
TEDDY Network will participate in the ENCePP plenary meeting that will be held on November 21st, 2017 at EMA in London
ENCePP is the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance coordinated by the European Medicines Agency (EMA) aimed to strengthen the monitoring of the benefit-risk balance of medicinal products in Europe.
On 31th May, 2017 the European Medicines Agency (EMA) published an action plan for small and medium-sized enterprises (SMEs), which aims to foster innovation and support SMEs in the development of novel human and veterinary